New Medication Shows Early Promise for Psoriasis Patients Part 2

A lot of work goes into a medication being approved for the public including many rounds of trials and adjustments along the way. For a new plaque psoriasis medication that work is well underway and the developers hope to have it to patients in the near future.

A lot of work goes into a medication being approved for the public including many rounds of trials and adjustments along the way. For a new plaque psoriasis medication that work is well underway and the developers hope to have it to patients in the near future.

Peter Piliero, MD, VP, Clinical Development & Medical Affairs, for Boehringer Ingelheim, discussed the work that has gone into their latest treatment option for the condition and what is left to be done during the American Academy of Dermatology's Annual Meeting in San Francisco.